Selenium biochemistry: selenoproteins and why they matter

Selenium occupies a unique position in human biochemistry. Unlike most trace minerals that function as enzyme cofactors by binding to active sites in their ionic form (as zinc or iron do), selenium is covalently incorporated into protein structures as the amino acid selenocysteine (Sec), the 21st genetically encoded amino acid. Selenocysteine is structurally identical to cysteine (a sulphur-containing amino acid) except that its sulphur atom is replaced by selenium.

This substitution confers dramatically different chemistry. Selenocysteine has a pKa of approximately 5.2, meaning it is ionised and highly reactive at physiological pH (7.4), while cysteine (pKa 8.3) is predominantly non-ionised and less reactive under the same conditions. This higher reactivity makes selenoproteins far more efficient as redox enzymes than their sulphur-containing counterparts, which is why evolution preserved the energetically costly selenium incorporation machinery despite selenium's relative scarcity in the Earth's crust.

The human genome encodes 25 known selenoproteins, each translated using a specialised codon reassignment mechanism (the UGA codon that normally signals stop is read as selenocysteine when a Sec insertion sequence element is present in the mRNA). The most clinically important selenoproteins for oral health are the glutathione peroxidases (GPx1, GPx2, GPx3, GPx4), which reduce hydrogen peroxide and lipid hydroperoxides at the expense of reduced glutathione; the thioredoxin reductases (TrxR1, TrxR2), which regenerate the thioredoxin antioxidant system; and selenoprotein P (SePP1), the primary selenium transport protein that delivers selenium from the liver to peripheral tissues including oral tissues.

When dietary selenium is insufficient, the body prioritises synthesis of the most critical selenoproteins (particularly GPx4, which protects against mitochondrial lipid peroxidation, and selenoprotein P for transport) at the expense of others. This hierarchy means that tissues with the highest metabolic demands and highest exposure to oxidative stress (including gingival tissue and immune cells) may experience selenoprotein insufficiency before any clinical signs of deficiency become apparent.

Selenium in dental tissues: what concentrations reveal

Selenium is naturally present in dental hard tissues, incorporated during amelogenesis and dentinogenesis at levels that reflect systemic selenium status during tooth development. Published analyses of enamel selenium concentrations in permanent teeth from different geographic regions show values ranging from approximately 0.01 to 0.5 parts per million (micrograms per gram), with the highest concentrations in enamel near the dentino-enamel junction and in dentin. These concentrations are far below the levels associated with selenosis (pathological selenium accumulation) but are sufficient to participate in local chemistry at the crystal surface.

Geochemical ecological studies have compared caries prevalence across regions with different soil and groundwater selenium concentrations. A well-cited series of analyses from different US states and Chinese provinces found consistent negative correlations between environmental selenium availability and dental caries rates in children. Low-selenium regions (below 0.1 micrograms per litre in drinking water) showed caries prevalence 20 to 40% higher than high-selenium regions (0.4 to 1.0 micrograms per litre) in several of these ecological comparisons.

The mechanistic interpretation of these ecological data is complicated by confounding factors: regions differ in fluoride levels, socioeconomic conditions, sugar access, and dental care availability. Nevertheless, two plausible biological mechanisms have been proposed. First, selenium at low concentrations inhibits Streptococcus mutans growth and glucosyltransferase activity in vitro, suggesting that selenium incorporated into enamel from saliva may provide a local antibacterial effect against cariogenic species. Second, selenium interacts with fluoride in hydroxyapatite crystal structure: selenate (SeO4 2-) can substitute for phosphate in the apatite lattice at the crystal surface, and fluoride can stabilise the resulting selenohydroxyapatite structure against acid dissolution.

These interactions between selenium and the hydroxyapatite crystal structure are mechanistically interesting but remain incompletely understood. The primary determinant of enamel acid resistance is still the substitution of fluoride for hydroxyl in the apatite lattice (forming fluorapatite) or the delivery of nano-hydroxyapatite to the enamel surface, both of which operate at substantially larger scale than the trace selenium contribution.

Selenium and antioxidant defence in the periodontal sulcus

The connection between selenium and gum disease is mechanistically coherent when viewed through the lens of oxidative stress biology in periodontitis. As discussed in the CoQ10 and collagen articles in this series, the periodontal sulcus during active disease is an environment of intense oxidative challenge. Neutrophils recruited to control subgingival bacteria generate massive quantities of reactive oxygen species (superoxide, hydrogen peroxide, hypochlorous acid) through NADPH oxidase-mediated respiratory burst.

Glutathione peroxidases (GPx1-4), the primary selenium-dependent antioxidant enzymes, are the main cellular defence against hydrogen peroxide in gingival tissue. GPx1 (cytosolic) and GPx4 (phospholipid hydroperoxide GPx) are expressed in gingival fibroblasts, epithelial cells, and infiltrating immune cells in the periodontium. Their activity limits oxidative damage to cell membranes, DNA, and extracellular matrix proteins from hydrogen peroxide that escapes the neutrophil phagosome.

Research published in the Journal of Periodontology found that total GPx activity in gingival crevicular fluid from periodontitis sites was significantly lower than from healthy sites in the same patients, consistent with either locally depleted selenium status or increased oxidative consumption of GPx activity beyond the capacity to replace it. Patients with the most severe periodontitis showed the lowest GPx activity and the highest oxidative stress biomarker concentrations (measured as 8-isoprostane and total antioxidant capacity), suggesting that GPx depletion contributes to the progressive tissue destruction that characterises severe disease.

A 2020 case-control study published in Clinical Oral Investigations measured serum selenium concentrations in 45 patients with chronic generalised periodontitis (Stage III or IV) and 40 age- and sex-matched periodontally healthy controls. Patients with periodontitis had significantly lower serum selenium (mean 74.3 micrograms per litre vs 91.8 micrograms per litre in controls), and within the periodontitis group, serum selenium correlated inversely with both mean pocket depth and clinical attachment loss. After adjusting for smoking, diabetes, and BMI, serum selenium remained a significant predictor of periodontitis severity, with an odds ratio of 2.4 for the lowest versus highest tertile of serum selenium.

The dual nature of selenium: essential versus toxic

Selenium is one of the few essential trace minerals where the therapeutic window between deficiency and toxicity is narrow enough to create genuine clinical management challenges. The range between the requirement for adequate selenoprotein function (approximately 75 to 100 micrograms per day) and the onset of subclinical toxicity (above 300 to 400 micrograms per day) is only a 3- to 4-fold difference. By comparison, the therapeutic window for zinc or iron is much wider.

At deficient intakes (below 30 to 40 micrograms per day), GPx activity falls, thioredoxin reductase activity diminishes, selenoprotein P concentrations drop, and tissues become more vulnerable to oxidative damage. Clinically, selenium deficiency is associated with Keshan disease (a selenoprotein-deficiency cardiomyopathy documented in low-selenium regions of China), impaired immune function, thyroid dysfunction, and as discussed, increased susceptibility to periodontitis and potentially to dental caries through the mechanisms outlined above.

At toxic intakes (above 800 to 1,000 micrograms per day chronically), selenosis manifests with a characteristic clinical picture that includes garlic-breath halitosis (from volatile dimethylselenide and dimethyldiselenide exhaled through the lungs), brittle nails with longitudinal ridging, hair loss, peripheral neuropathy, and, critically for oral health, dental changes. Selenosis produces mottled, chalky-white enamel spots that progress to brown discolouration and enamel pitting in more severe cases. The clinical appearance can be difficult to distinguish from dental fluorosis. Histological examination of teeth from individuals with selenosis shows disrupted ameloblast function during development, with areas of hypomineralisation surrounded by relatively normal enamel, producing the characteristic mottled pattern.

Selenium and the oral microbiome

Beyond its host antioxidant functions, selenium influences the oral microbiome through direct antibacterial effects and through modulation of the immune environment that shapes bacterial community ecology. These two pathways operate simultaneously and can be difficult to distinguish in vivo.

In vitro studies have demonstrated that selenite (SeO3 2-, an inorganic selenium anion) at concentrations in the low micromolar range inhibits S. mutans growth by interfering with thiol-dependent enzymes in bacterial glycolysis. The mechanism is distinct from selenium's role in mammalian selenoproteins: bacterial cells lack the selenocysteine incorporation machinery and are therefore more vulnerable to inorganic selenium species that oxidise bacterial thiol groups in enzyme active sites. Whether salivary selenium concentrations are sufficient to produce this in vivo antibacterial effect is uncertain, as salivary selenium values are low (typically 1 to 10 nanograms per millilitre in healthy adults) and the concentrations required for inhibitory effects in vitro are typically 10- to 100-fold higher.

The immune-mediated pathway is more plausible as a clinical driver of microbiome ecology. Adequate selenium supports normal neutrophil and macrophage function in the sulcus, maintaining the host immune surveillance that keeps subgingival bacterial communities in the health-associated homeostatic range. When selenium status is insufficient and GPx activity falls, neutrophils become less efficient at killing phagocytosed bacteria while producing equivalent amounts of reactive oxygen species that damage host tissue. This creates an environment of increased bacterial viability and increased tissue damage, exactly the conditions that favour the growth of gram-negative anaerobic periodontal pathogens over commensal aerobic species.

Research in murine periodontitis models has found that selenium supplementation (raising serum selenium from deficient to adequate levels) shifts the subgingival microbiome toward health-associated compositions and reduces alveolar bone loss in ligature-induced periodontitis, even without changes to oral hygiene. These animal data cannot be directly extrapolated to humans but provide mechanistic support for the hypothesis that systemic selenium status influences the periodontal microbiome ecology through the immune function pathway.

Selenium and oral cancer: a research connection

Selenium's role in antioxidant defence and immune function extends to cancer prevention research. Oral squamous cell carcinoma (OSCC), the most common malignancy of the oral cavity, is associated with chronic oxidative DNA damage from tobacco, alcohol, and certain viral infections (HPV in some anatomical sites). Selenoproteins including GPx1, GPx2, and thioredoxin reductase protect cells against the kind of chronic oxidative DNA damage that initiates carcinogenic mutations.

A meta-analysis published in the European Journal of Cancer in 2018 examined selenium status and oral cancer risk across 12 case-control studies involving over 2,000 OSCC patients. Lower serum selenium was associated with significantly higher OSCC risk (pooled odds ratio 2.1 for lowest vs highest quartile), with the association strongest in studies from regions with low background selenium in the food supply. This is observational data subject to reverse causation (cancer may deplete selenium) and confounding (low selenium areas may differ in other dietary patterns).

Several selenoproteins also have direct tumour-suppressive activity. Thioredoxin reductase supports the p53 tumour suppressor protein's DNA-binding function, which is critical for apoptosis of cells with mutated DNA. GPx2, which is particularly high in gastrointestinal and oral mucosa, appears to limit the proliferative signalling that drives early-stage malignant transformation. Whether selenium supplementation reduces OSCC risk in selenium-sufficient populations has not been tested in a randomised trial, and existing evidence is insufficient to support supplementation specifically for oral cancer prevention beyond ensuring adequate intake.

Dietary selenium sources and assessing your intake

Selenium content in foods varies dramatically by geography because it reflects the selenium concentration in soil where plants are grown and animals are raised. This creates significant within-country variation in dietary selenium intake that is difficult to assess without knowing the specific origin of food products.

Brazil nuts from the Amazonian basin are the richest and most variable source, containing 70 to 4,000 micrograms of selenium per nut depending on the specific growing region. A single Brazil nut can theoretically provide anywhere from the daily requirement to multiples of the tolerable upper intake level, making them a food where the dose-uncertainty is practically significant. Eating 1 to 2 Brazil nuts from mixed origins daily is a common approach to selenium supplementation through food, but the variability makes it unreliable for precision dosing.

More predictable selenium sources include organ meats (kidney: 140 micrograms per 100 g; liver: 40 to 60 micrograms per 100 g), seafood (tuna: 90 to 100 micrograms per 100 g; cod: 30 to 40 micrograms per 100 g; shrimp: 35 to 40 micrograms per 100 g), eggs (15 to 20 micrograms per egg), and wholegrains from selenium-rich regions (wheat grown in high-selenium soil can provide 10 to 50 micrograms per 100 g, but wheat from Europe often provides only 2 to 5 micrograms per 100 g due to low European soil selenium).

European populations are among the lowest selenium status groups in developed countries, with mean serum selenium concentrations in Northern and Central Europe typically 70 to 90 micrograms per litre, near or below the threshold for full selenoprotein saturation. This makes selenium monitoring and supplementation particularly relevant for European readers. Supplemental forms with established bioavailability include selenomethionine (the form in most supplements, well-absorbed and stored in muscle proteins as a selenium reserve) and selenite (inorganic, rapidly utilised for selenoprotein synthesis).

Integrating selenium into a complete oral health strategy

Selenium occupies a specific niche in oral health nutrition: it is primarily relevant as a systemic antioxidant and immune support mineral rather than as a direct enamel or gum repair agent. Its contribution to oral health operates through the background selenoprotein activity that determines how effectively gingival tissue withstands oxidative challenge and how competently neutrophils patrol the periodontal sulcus.

For European readers in particular, ensuring selenium intake reaches the 75 to 100 microgram per day range for full selenoprotein saturation is a reasonable goal, achievable through 2 to 3 weekly servings of fish and shellfish, regular egg consumption, and occasional organ meats, supplemented with 50 to 100 micrograms of selenomethionine if dietary intake assessment suggests a shortfall.

The other trace mineral nutrients discussed in this article series, particularly zinc (discussed in the companion article on zinc deficiency and oral health) and vitamin K2 (explored in the vitamin K2 MK-7 article), work through complementary but distinct pathways. Zinc supports the collagen cross-linking and alkaline phosphatase activity needed for mineralisation and structural integrity; K2 directs calcium into alveolar bone; selenium provides the redox protection that limits tissue damage from the inflammatory response. All three are necessary for the periodontium to function optimally, and addressing any single mineral in isolation is unlikely to produce substantial clinical benefit if the others are deficient.

The enamel surface, which is the most commonly damaged dental structure in adults, requires a different category of intervention entirely. Enamel mineral is lost when acid (from bacteria or diet) dissolves hydroxyapatite crystals below pH 5.5, and it can only be recovered through surface contact with remineralising ions. Systemic selenium, however adequate, cannot reach the enamel surface through blood supply. Nano-hydroxyapatite delivered directly to the enamel surface by Minvelle remineralising gum provides the bioavailable mineral that fills this gap, working at the crystal surface level where acid erosion occurs and remineralisation is possible.

Frequently asked questions